Dual role of TGFBR3 in bladder cancer

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.30, Iss.3, 2013-01, pp. : 1301-1308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1027-1035

Spandidos Publications

Access to resources Recommend Favorite

Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 377-383

Spandidos Publications

Access to resources Recommend Favorite

Role of MMP - 3 and MMP - 9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

By Srivastava Priyanka

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3068-3075

Springer Publishing Company

Access to resources Recommend Favorite

Matrix metalloproteinases: a dual role in breast cancer?

By Decock Julie Roghi Christian Edwards Dylan R

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

The dual role of TLR3 in metastatic cell line

By Matijevic Tanja

Clinical and Experimental Metastasis, Vol. 28, Iss. 7, 2011-10 ,pp. : 701-712

Springer Publishing Company

Access to resources Recommend Favorite